Company Dashboard
Explore stock charts, earnings, outlooks, and dividends for any company.
Agios Pharmaceuticals, Inc. ( NASDAQ : AGIO )
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
|
—
|
37.32
(
+0.32
/
+0.86%
)
|
—
|
| — | 26-Oct 12:18 | 22-Oct 15:59 |
| Previous Close | 37.00 | 52-Week Low | 22.24 |
| Open | 37.55 | 52-Week High | 46.00 |
| Day Low | 37.02 | 50-Day Average | 33.08 |
| Day High | 38.08 | 200-Day Average | 31.21 |
| Volume | 14.12 K | Market Cap | 1.85 B |
AGIO Earnings Calendar
Earnings reports, estimates, results and year-over-year growth for AGIO.
Showing
1 –
5
of
5
earnings records
from
2025-07-31
to
2026-07-30
| Symbol | Date | Time | Period | Metric | Actual | Estimate | Prior Year | Surprise | Growth | News |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
2026-07-30 | BMO | Q2 2026 | EPS | $-1.69 | $-1.67 | $-1.93 | Miss (-1.20%) | Up (+12.44%) | View |
| REV | $44.75 M | $25.52 M | $12.46 M | Beat (+75.35%) | Up (+259.15%) | |||||
|
|
2026-04-29 | BMO | Q1 2026 | EPS | $-1.69 | $-1.80 | $-1.55 | Beat (+6.11%) | Down (-9.03%) | View |
| REV | $20.75 M | $13.65 M | $8.73 M | Beat (+52.01%) | Up (+137.69%) | |||||
|
|
2026-02-12 | BMO | Q4 2025 | EPS | $-1.86 | $-1.95 | $-1.94 | Beat (+4.62%) | Up (+4.12%) | View |
| REV | $19.97 M | $12.01 M | $10.70 M | Beat (+66.28%) | Up (+86.64%) | |||||
|
|
2025-10-30 | BMO | Q3 2025 | EPS | $-1.78 | $-1.90 | $-1.43 | Beat (+6.32%) | Down (-24.48%) | View |
| REV | $12.88 M | $10.42 M | $8.96 M | Beat (+23.61%) | Up (+43.75%) | |||||
|
|
2025-07-31 | BMO | Q2 2025 | EPS | $-1.93 | $-1.81 | $-1.69 | Miss (-6.63%) | Down (-14.20%) | View |
| REV | $12.46 M | $9.54 M | $8.62 M | Beat (+30.61%) | Up (+44.55%) |
Sign up to see MORE data
Create your FREE CatalystPICR account to access additional company data.
Sign Up Free